Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
Colorcon
Citi
Federal Trade Commission
Teva
Healthtrust
Fish and Richardson
Daiichi Sankyo

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,679,685

« Back to Dashboard

Summary for Patent: 5,679,685
Title: Accelerated release composition containing bromocriptine
Abstract:Disclosed herein is a solid oral dosage form comprising bromocriptine and one or more pharmaceutically acceptable excipients. The oral dosage form has a dissolution rate in excess of 90% in 5 minutes in 500 ml of 0.1N HCl aqueous medium at 37 C and is useful for adjusting the plasma prolactin profile of a patient.
Inventor(s): Cincotta; Anthony H. (Andover, MA), Cincotta, Jr.; Manuel (Tiverton, RI), Pelloni; Christopher Louis (Louisville, CO), Runice; Christopher Eric (Denver, CO), Tigner; Sandra Louise (Broomfield, CO)
Assignee: Ergo Science, Incorporated (Charlestown, MA) Geneva Pharmaceuticals, Inc. (Broomfield, CO)
Application Number:08/459,021
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

Drugs Protected by US Patent 5,679,685

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Express Scripts
Johnson and Johnson
Fuji
Fish and Richardson
Julphar
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.